| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 5 |
| 1 | ETANERCEPT | 3 |
| 2 | OMEPRAZOLE MAGNESIUM | 3 |
| 3 | ALPRAZOLAM | 2 |
| 4 | ERGOCALCIFEROL | 2 |
| 5 | LEFLUNOMIDE | 2 |
| 6 | LEVOTHYROXINE SODIUM | 2 |
| 7 | METOCLOPRAMIDE HYDROCHLORIDE | 2 |
| 8 | OMEPRAZOLE | 2 |
| 9 | PREDNISONE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BEPOTASTINE BESILATE | 1 | 0.0016 |
| 1 | DANAZOL | 1 | 0.0004 |
| 2 | BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | 1 | 0.0003 |
| 3 | LANADELUMAB-FLYO | 1 | 0.0003 |
| 4 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 5 | HYDROCORTISONE SODIUM SUCCINATE | 1 | 0.0003 |
| 6 | CARBOXYMETHYLCELLULOSE SODIUM | 1 | 0.0002 |
| 7 | TEPROTUMUMAB | 1 | 0.0002 |
| 8 | FONDAPARINUX SODIUM | 1 | 0.0001 |
| 9 | CABOTEGRAVIR | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Benzodiazepine [EPC] | 5 |
| 1 | Corticosteroid [EPC] | 4 |
| 2 | Tumor Necrosis Factor Blocker [EPC] | 4 |
| 3 | Osmotic Laxative [EPC] | 3 |
| 4 | Proton Pump Inhibitor [EPC] | 3 |
| 5 | Amide Local Anesthetic [EPC] | 2 |
| 6 | Antirheumatic Agent [EPC] | 2 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 2 |
| 8 | Estrogen [EPC] | 2 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 2 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 1 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |
| 3 | GLP-2 Analog [EPC] | 1 | 0.0001 |
| 4 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 5 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 7 | Bile Acid [EPC] | 1 | 0.0000 |
| 8 | Aluminum Complex [EPC] | 1 | 0.0000 |
| 9 | Androgen [EPC] | 1 | 0.0000 |